Back to search

Belgium· BE-AMP-SAM181282-00

Lactulose EG 670 mg/ml

A lactulose product containing lactulose, registered in Belgium by EG. The same ATC class is registered in 16 of our 19 countries.

ATC A06AD11

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLactulose EG 670 mg/mlATCA06AD11REGISTER NO.BE-AMP-SAM181282-00PACKS LISTED3CHECKEDSeptember 26, 2026

Where it is registered

Lactulose is registered in 16 of 19 countries.

Countries holding a registration under ATC A06AD11 (lactulose), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Lactulose · ATC A06AD11

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Lactulose
Manufacturer
EG
Country
Belgium (BE)
ATC code
A06AD11
ATC class
Lactulose
Defined daily dose
12.5 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    1342609
  • be_apb
    1342617
  • be_apb
    1455450

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

657 interactions on record for lactulose.

Graded by severity as the source publishes them — 263 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lactulose · interactions on record

657 records

  • 263 moderate
  • 18 minor
  • 376 info

Most severe, free to view

  • CisaprideA03FA02moderate
  • OndansetronA04AA01moderate
  • GranisetronA04AA02moderate
  • DolasetronA04AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lactulose in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lactulose products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Duphalac Fruit, Lactulose Genericon
  • Bulgaria · Дуфалак, Лактулакс
  • Cyprus · Duphalac
  • Czechia · Duphalac, Lactulosa Biomedica
  • Germany · Bifiteral, Bifiteral Mit Pflaumenaroma
  • Denmark · Lactulose Orifarm, Medilax
  • Estonia · Duphalac, Duphalac Fruit
  • Spain · Duphalac, Lactulosa Lainco
  • Finland · Duphalac, Duphalac Fruit
  • France · Duphalac, Lactulose Arrow
  • United Kingdom (Northern Ireland) · Lactolax, Lactulose
  • Greece · Duphafruit, Duphalac
  • Croatia · Portalak, Portalak Efekt
  • Ireland · Brillphalac, Lactecon
  • Iceland · Medilax
  • Italy · Duphalac, Epalfen Eps
  • Lithuania · Duphalac, Duphalac Fruit
  • Luxembourg · Bifiteral, Duphalac
  • Latvia · Duphalac Fruit, Lactulose Mip
  • Malta · Duphalac, Lactulose
  • Netherlands · Duphalac, Duphalac Fruit
  • Norway · Duphalac, Duphalac Med Fruktsmak
  • Poland · Duphalac, Duphalac Fruit
  • Portugal · Duphalac, Duphalac Ameixa
  • Romania · Duphalac Fruit, Lactecon
  • Sweden · Duphalac, Laktulos Cooper
  • Slovenia · Prorektal
  • Slovakia · Duphalac, Lactecon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c0ccc26e-113d-458e-a27d-c8c4c0e70e74
GET /v1/drugs/c0ccc26e-113d-458e-a27d-c8c4c0e70e74?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Syrup",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Lactulose EG 670 mg/ml",
  "name_fr": "Lactulose EG 670 mg/ml",
  "name_nl": "Lactulose EG 670 mg/ml",
  "amp_code": "SAM181282-00",
  "strengths": [
    "670.0000",
    "670.0000"
  ],
  "pack_count": 11,
  "substances": [
    "Lactulose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Lactulose",
  "authorisation_numbers": [
    "BE181282",
    "BE181316",
    "BE181325",
    "BE181334"
  ]
}

See everything about lactulose.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.